Many patients are offered hope by therapeutic strategies, which were revolutionized by the drug, a precision medicine for NSCLC (NSCLC).However, possible kidney toxicity of it has emerged as a worry.This article aims to provide a detailed examination of all aspects including the prevalence, possible causes, diagnosis standards, and treatment methods of the drug nephrotoxicity.

It is regarded as low, however the prevalence of the drug nephrotoxicity varies among studies.However, it is important to recognize the increased risk in target patient populations, which includes those with previous kidney dysfunction or simultaneous administration of kidney-toxic drugs.Several possible causes have been identified that are connected to the drug nephrotoxicity.

By understanding these possible causes, one can distinguish patients at greater risk and to apply suitable preventative steps.The existence of specific clinical and lab findings is vital to diagnosing the drug nephrotoxicity.prompt identification and diagnosis of the drug nephrotoxicity are essential for swift intervention and treatment.

A interdisciplinary approach is involved in the control of Tagrisso treatment-related renal toxicity.In this article, we will examine each aspect, aiming to provide a thorough knowledge of Tagrisso treatment-related renal toxicity and its relevance to clinical application.Aim of doing so is to improve patient results by improving the detection, control, and avoidance of this side effect.